Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum

S Capaccioli1, G Di Pasquale, E Mini

  • 1Institute of General Pathology, Firenze, Italy.

Insights

Cationic lipids like DOTAP significantly boost cellular uptake and prevent degradation of antisense oligonucleotides (aODN), overcoming key limitations for gene regulation. These findings suggest cationic lipids are promising for aODN delivery.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Expression Regulation

Background:

  • Antisense oligonucleotides (aODN) show promise for gene regulation but face challenges with cellular uptake and nuclease degradation.
  • Efficient delivery of aODN into cells is critical for their therapeutic and research applications.

Purpose of the Study:

  • To investigate the effect of artificial cationic lipids on the cellular uptake and nuclease-mediated degradation of antisense oligonucleotides (aODN).
  • To evaluate the potential of cationic lipids as vehicles for enhancing aODN delivery and stability.

Main Methods:

  • Experiments were conducted using cell cultures and human serum to assess ODN uptake and degradation in the presence of cationic lipids.
  • The study utilized specific cationic lipids, including DOTAP, DOTMA, and DOGS, to evaluate their impact on ODN behavior.

Main Results:

  • DOTAP enhanced ODN cellular uptake over 25-fold at typical experimental concentrations, suggesting a bypass of saturable endocytosis.
  • Cationic lipids, particularly DOTAP, significantly inhibited ODN degradation by nucleases in both cell cultures and human serum.
  • Other tested cationic lipids (DOTMA, DOGS) demonstrated similar beneficial effects on ODN uptake and stability.

Conclusions:

  • Artificial cationic lipids effectively enhance cellular uptake and protect antisense oligonucleotides from degradation.
  • These lipids show potential as suitable vehicles for antisense oligonucleotide (aODN) delivery, overcoming major biological barriers.
  • The findings support the use of cationic lipids in advancing gene regulation strategies using aODN.

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...